1. • Parietti-Winkler C, Baumann C, Gallet P, et al. Otitis media with effusion as a marker of the inflammatory process associated to nasal polyposis. Rhinology 2009;47(4):396–9. In this study, authors compared the charts of 25 patients presenting with NP and developing OME with those of 50 patients presenting with isolated NP. The authors showed that the risk of developing OME in NP patients is higher than in patients presenting with the AT (NP associated with asthma and aspirin sensitivity), and that a linear trend exists between the different degrees of inflammatory respiratory disease and the risk of developing OME. The authors suggest that the development of OME could be considered one more step in severity of the underlying inflammatory respiratory disease leading to NP, asthma, and AI, and that the middle ear should be included in a concept of united airways inflammatory disease. This study highlights an association between OME and NP, based on the assessment of patients presenting with NP.
2. Nagamine H, Iino Y, Kojima C, Miyazawa Y, et al. Clinical characteristics of so called eosinophilic otitis media. Auris Nasus Larynx. 2002;29:19–28.
3. Iino Y, Tomioka-Matsutani S, Matsubara A, et al. Diagnostic criteria of eosinophilic otitis media, a newly recognized middle ear disease. Auris Nasus Larynx. 2011;38:456–61.
4. Corbeel L. What is new in otitis media? Eur J Pediatr. 2007;166:511–9.
5. Tran Ba Huy P, Sauvaget E, Portier F. Seromucous otitis. Ann Otolaryngol Chir Cervicofac. 2007;124:120–5.